Correlation Between Verve Therapeutics and Tempus AI,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Tempus AI, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Tempus AI, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and Tempus AI, Class, you can compare the effects of market volatilities on Verve Therapeutics and Tempus AI, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Tempus AI,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Tempus AI,.

Diversification Opportunities for Verve Therapeutics and Tempus AI,

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Verve and Tempus is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Tempus AI, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempus AI, Class and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Tempus AI,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempus AI, Class has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Tempus AI, go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Tempus AI,

Given the investment horizon of 90 days Verve Therapeutics is expected to under-perform the Tempus AI,. But the stock apears to be less risky and, when comparing its historical volatility, Verve Therapeutics is 1.31 times less risky than Tempus AI,. The stock trades about -0.44 of its potential returns per unit of risk. The Tempus AI, Class is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  4,517  in Tempus AI, Class on January 7, 2025 and sell it today you would lose (259.00) from holding Tempus AI, Class or give up 5.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Verve Therapeutics  vs.  Tempus AI, Class

 Performance 
       Timeline  
Verve Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in May 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Tempus AI, Class 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tempus AI, Class are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile technical and fundamental indicators, Tempus AI, displayed solid returns over the last few months and may actually be approaching a breakup point.

Verve Therapeutics and Tempus AI, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verve Therapeutics and Tempus AI,

The main advantage of trading using opposite Verve Therapeutics and Tempus AI, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Tempus AI, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempus AI, will offset losses from the drop in Tempus AI,'s long position.
The idea behind Verve Therapeutics and Tempus AI, Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated